About 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid
2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid (PubChem CID 157063347) has the molecular formula C40H44N4O6
and a molecular weight of 676.81 g/mol. Its IUPAC name is 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid.
Molecular Properties
| Compound Name | 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid |
| PubChem CID | 157063347 |
| Molecular Formula | C40H44N4O6 |
| Molecular Weight | 676.81 g/mol |
| Exact Mass | 676.33 |
| IUPAC Name | 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid |
| SMILES | COc1cc(C(=O)O)ccc1CN1CCOCC1.Cc1cc(C(=O)Cc2ccccc2-c2nc3ccccc3[nH]2)ccc1CN1CCOCC1 |
| InChI | InChI=1S/C27H27N3O2.C13H17NO4/c1-19-16-21(10-11-22(19)18-30-12-14-32-15-13-30)26(31)17-20-6-2-3-7-23(20)27-28-24-8-4-5-9-25(24)29-27;1-17-12-8-10(13(15)16)2-3-11(12)9-14-4-6-18-7-5-14/h2-11,16H,12-15,17-18H2,1H3,(H,28,29);2-3,8H,4-7,9H2,1H3,(H,15,16) |
| InChIKey | ABOUMVMVQXJFHL-UHFFFAOYSA-N |
| XLogP | 6.02 |
| TPSA | 117.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 676.81 |
| LogP ≤ 5 | 6.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid?
The IUPAC name of 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid (CID 157063347) is 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid.
What is the SMILES notation for 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid?
The canonical SMILES for 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid is COc1cc(C(=O)O)ccc1CN1CCOCC1.Cc1cc(C(=O)Cc2ccccc2-c2nc3ccccc3[nH]2)ccc1CN1CCOCC1.
What is the InChIKey of 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid?
The InChIKey is ABOUMVMVQXJFHL-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H27N3O2.C13H17NO4/c1-19-16-21(10-11-22(19)18-30-12-14-32-15-13-30)26(31)17-20-6-2-3-7-23(20)27-28-24-8-4-5-9-25(24)29-27;1-17-12-8-10(13(15)16)2-3-11(12)9-14-4-6-18-7-5-14/h2-11,16H,12-15,17-18H2,1H3,(H,28,29);2-3,8H,4-7,9H2,1H3,(H,15,16).
What are the key properties of 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid?
2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid has a molecular weight of 676.81 g/mol, XLogP of 6.02, 10 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(1H-benzimidazol-2-yl)phenyl]-1-[3-methyl-4-(morpholin-4-ylmethyl)phenyl]ethanone;3-methoxy-4-(morpholin-4-ylmethyl)benzoic acid is sourced from PubChem (CID 157063347), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).